?In an interview at the European Atherosclerosis Society (EAS) Congress, Alberico L. Catapano said that Heterozygous FH is the "most frequent monogenic disease" in Europe. The University of Milan researcher called on the European Union to "urge member states to provide information to physicians in order to be able to detect to the disease" and to support additional genetic research into FH.

Contribute to our reporting

The need for fast, accurate and balanced information is always important. We value EURACTIV's good, independent journalism and support this initiative

Mella Frewen, Director General of FoodDrinkEurope

EURACTIV plays a vital role in bringing Europe closer to its citizens. EURACTIV has long recognised that the story of Europe has to be told across the continent, and not just in Brussels. We need to support a truly European and informed debate.